Senti Biosciences board member Brenda Cooperstone resigns effective immediately

Senti Biosciences, Inc.

Brenda Cooperstone, Ph.D. resigned from the Board on September 23, 2026, effective immediately.
Cooperstone also stepped down as Chair of the Compensation Committee, effective immediately.
Resignation was not due to any disagreement with Senti on operations, policies, or practices.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Brenda Cooperstone

Director

SNTI · Senti Biosciences, Inc.

Effective: 2026-09-23
Filed: September 24, 2026, 4:03 PM ET

On September 23, 2026, Brenda Cooperstone, Ph.D., notified the Board of Directors (the "Board") of Senti Biosciences Holdings, Inc. (the "Company") of her decision to resign from the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Brenda Cooperstone resigned as Director at Senti Biosciences, Inc..

Action: resigned
Role: Director

Exact text from the filing

On September 23, 2026, Brenda Cooperstone, Ph.D., notified the Board of Directors (the "Board") of Senti Biosciences Holdings, Inc. (the "Company") of her decision to resign from the Board, effective immediately.

View on SEC.gov

Senti Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-063369

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.